These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 32748028)

  • 1. Evaluating the impact of AMPK activation, a target of metformin, on risk of cardiovascular diseases and cancer in the UK Biobank: a Mendelian randomisation study.
    Luo S; Schooling CM; Wong ICK; Au Yeung SL
    Diabetologia; 2020 Nov; 63(11):2349-2358. PubMed ID: 32748028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenosine 5'monophosphate-activated protein kinase activation reduces the risks of psoriasis and its comorbidities: a Mendelian randomization study in the UK Biobank.
    Xiao Y; Jing D; Zhou G; Tang Z; Peng C; Kuang Y; Zhu W; Chen X; Liu H; Shen M
    Rheumatology (Oxford); 2024 May; 63(6):1664-1671. PubMed ID: 37672020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of glycemic traits, type 2 diabetes and metformin use on breast and prostate cancer risk: a Mendelian randomization study.
    Au Yeung SL; Schooling CM
    BMJ Open Diabetes Res Care; 2019; 7(1):e000872. PubMed ID: 31908803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating the impact of metformin targets on the risk of osteoarthritis: a mendelian randomization study.
    Zhang Y; Li D; Zhu Z; Chen S; Lu M; Cao P; Chen T; Li S; Xue S; Zhang Y; Zhu J; Ruan G; Ding C
    Osteoarthritis Cartilage; 2022 Nov; 30(11):1506-1514. PubMed ID: 35803489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A data-driven approach for studying the role of body mass in multiple diseases: a phenome-wide registry-based case-control study in the UK Biobank.
    Hyppönen E; Mulugeta A; Zhou A; Santhanakrishnan VK
    Lancet Digit Health; 2019 Jul; 1(3):e116-e126. PubMed ID: 33323262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of GDF-15, a biomarker for metformin, on the risk of coronary artery disease, breast and colorectal cancer, and type 2 diabetes and metabolic traits: a Mendelian randomisation study.
    Au Yeung SL; Luo S; Schooling CM
    Diabetologia; 2019 Sep; 62(9):1638-1646. PubMed ID: 31161347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing the linear and non-linear association of HbA
    Luo S; Au Yeung SL; Schooling CM
    Diabetologia; 2021 Nov; 64(11):2502-2510. PubMed ID: 34345974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AMP-activated protein kinase is activated in adipose tissue of individuals with type 2 diabetes treated with metformin: a randomised glycaemia-controlled crossover study.
    Boyle JG; Logan PJ; Jones GC; Small M; Sattar N; Connell JM; Cleland SJ; Salt IP
    Diabetologia; 2011 Jul; 54(7):1799-809. PubMed ID: 21455728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating the efficacy and mechanism of metformin targets on reducing Alzheimer's disease risk in the general population: a Mendelian randomisation study.
    Zheng J; Xu M; Walker V; Yuan J; Korologou-Linden R; Robinson J; Huang P; Burgess S; Au Yeung SL; Luo S; Holmes MV; Davey Smith G; Ning G; Wang W; Gaunt TR; Bi Y
    Diabetologia; 2022 Oct; 65(10):1664-1675. PubMed ID: 35902387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of putative metformin targets on phenotypic age and leukocyte telomere length: a mendelian randomisation study using data from the UK Biobank.
    Luo S; Wong ICK; Chui CSL; Zheng J; Huang Y; Schooling CM; Yeung SLA
    Lancet Healthy Longev; 2023 Jul; 4(7):e337-e344. PubMed ID: 37421961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lean mass, grip strength and risk of type 2 diabetes: a bi-directional Mendelian randomisation study.
    Yeung CHC; Au Yeung SL; Fong SSM; Schooling CM
    Diabetologia; 2019 May; 62(5):789-799. PubMed ID: 30798333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the causal pathway from bilirubin to CVD and diabetes in the UK biobank cohort study: Observational findings and Mendelian randomization studies.
    Hou L; Li H; Si S; Yu Y; Sun X; Liu X; Yan R; Yu Y; Wang C; Yang F; Wang Q; Xue F
    Atherosclerosis; 2021 Mar; 320():112-121. PubMed ID: 33485635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding the consequences of education inequality on cardiovascular disease: mendelian randomisation study.
    Carter AR; Gill D; Davies NM; Taylor AE; Tillmann T; Vaucher J; Wootton RE; Munafò MR; Hemani G; Malik R; Seshadri S; Woo D; Burgess S; Davey Smith G; Holmes MV; Tzoulaki I; Howe LD; Dehghan A
    BMJ; 2019 May; 365():l1855. PubMed ID: 31122926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating the impact of glucokinase activation on risk of cardiovascular disease: a Mendelian randomisation analysis.
    Wang K; Shi M; Huang C; Fan B; Luk AOY; Kong APS; Ma RCW; Chan JCN; Chow E
    Cardiovasc Diabetol; 2022 Sep; 21(1):192. PubMed ID: 36151532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of metformin targets on cardiometabolic health in the general population and non-diabetic individuals: a Mendelian randomization study.
    Zheng J; Xu M; Yang Q; Hu C; Walker V; Lu J; Wang J; Liu R; Xu Y; Wang T; Zhao Z; Yuan J; Burgess S; Au Yeung SL; Luo S; Anderson EL; Holmes MV; Smith GD; Ning G; Wang W; Gaunt TR; Bi Y
    EBioMedicine; 2023 Oct; 96():104803. PubMed ID: 37734206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Body Mass Index With Cardiometabolic Disease in the UK Biobank: A Mendelian Randomization Study.
    Lyall DM; Celis-Morales C; Ward J; Iliodromiti S; Anderson JJ; Gill JMR; Smith DJ; Ntuk UE; Mackay DF; Holmes MV; Sattar N; Pell JP
    JAMA Cardiol; 2017 Aug; 2(8):882-889. PubMed ID: 28678979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of genetically predicted testosterone with thromboembolism, heart failure, and myocardial infarction: mendelian randomisation study in UK Biobank.
    Luo S; Au Yeung SL; Zhao JV; Burgess S; Schooling CM
    BMJ; 2019 Mar; 364():l476. PubMed ID: 30842065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetically determined serum urate levels and cardiovascular and other diseases in UK Biobank cohort: A phenome-wide mendelian randomization study.
    Li X; Meng X; He Y; Spiliopoulou A; Timofeeva M; Wei WQ; Gifford A; Yang T; Varley T; Tzoulaki I; Joshi P; Denny JC; Mckeigue P; Campbell H; Theodoratou E
    PLoS Med; 2019 Oct; 16(10):e1002937. PubMed ID: 31626644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effects of metformin in various cardiovascular diseases: Clinical evidence and AMPK-dependent mechanisms.
    Bu Y; Peng M; Tang X; Xu X; Wu Y; Chen AF; Yang X
    J Cell Mol Med; 2022 Oct; 26(19):4886-4903. PubMed ID: 36052760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Height and overall cancer risk and mortality: evidence from a Mendelian randomisation study on 310,000 UK Biobank participants.
    Ong JS; An J; Law MH; Whiteman DC; Neale RE; Gharahkhani P; MacGregor S
    Br J Cancer; 2018 May; 118(9):1262-1267. PubMed ID: 29581483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.